Male hypogonadism

3 papers

Trial sponsors

Endo USA
Company2 trialsPhase 4707 people
Azurity Pharmaceuticals
Company1 trialPhase 4144 people
Clarus Therapeutics
Company6 trialsPhase 3695 people
Lipocine
Company1 trialPhase 3315 people
Acerus Pharmaceuticals Corporation
Company1 trialPhase 3306 people
Halozyme Therapeutics
Company1 trialPhase 3100 people
Neurocrine UK
Company1 trialPhase 125 people
University of Miami
2 trialsPhase 4116 people

Latest

2 in 12 months

Pharmaceuticals27 Aug

Effects of Incretin-Based Therapies on Testosterone Levels and Incretin Response in Men with Hypogonadism: A Systematic Literature Review Following PRISMA 2020 Guidelines

Systematic review of studies in peopleInterventions

The World Journal of Men's Health17 Aug

Can Glucagon-Like Peptide-1 Receptor Agonists or Sodium-Glucose Cotransporter 2 Inhibitors Be Considered New Treatment Options for Male Hypogonadism and Sexual Dysfunction?

ReviewSGLT2 inhibitors

The Journal of Sexual Medicine1 Mar

Update in testosterone therapy for men

Systematic reviewTestosterone